InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Demetri George, Director. Officer active across 1 companies, notably Blueprint Medicines Corp. In total, 3 disclosures have been recorded. Total volume traded: €702. The latest transaction was filed on 13 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€70210 shares@ €70.1974100.0% of flow
Common Stock
SEC:0001415889-22-007129:0·
Ideal exit: 9 Apr 2022 (T+270)
02,250 shares0
Common Stock
SEC:0001179110-21-006418·
02,250 shares0
Common Stock
SEC:0001179110-21-006418:0·
3 of 3 declarations
About Demetri George
Demetri George is a Board Member at Blueprint Medicines Corp. He plays a vital role in the governance of the company, providing strategic advice and overseeing development initiatives.
